Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Tubular Breast Cancer|Mucinous Breast Cancer|Invasive Ductal Breast Cancer|Inflammatory Breast Cancer
Interventions: DRUG: Paclitaxel|DRUG: Cisplatin|DRUG: Gonadotropin-releasing hormone agonist|DRUG: Letrozole
Sponsor: RenJi Hospital